CIK 0001348362 · Non-accelerated filer<br>Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 202000871
- Phone
- 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | BUNKA CHRISTOPHER Director | Gift | −100,000 | 273,543 | ||
| 2025-07-30 | BUNKA CHRISTOPHER Director | Purchase | +11,900 | $0.91 | $11K | 281,912 |
| 2025-07-29 | BUNKA CHRISTOPHER Director | Purchase | +15,600 | $0.92 | $14K | 270,012 |
| 2025-07-29 | McKechnie William Edward Director | Purchase | +5,000 | $0.91 | $5K | 18,191 |
| 2025-07-29 | DOCHERTY JOHN MARTIN President & CSO | Purchase | +5,376 | $0.93 | $5K | 5,376 |
| 2025-07-29 | Carle Vanessa Secretary | Purchase | +750 | $0.91 | $683 | 750 |
| 2025-07-29 | CHRISTOPHER RICHARD Chief Executive Officer | Purchase | +15,000 | $0.91 | $14K | 65,000 |
| 2025-05-15 | CHRISTOPHER RICHARD Chief Executive Officer | Grant or award · Stock Options | +150,000 | 350,000 | ||
| 2025-05-15 | BUNKA CHRISTOPHER Director | Grant or award · Stock Options | +11,000 | 184,834 | ||
| 2025-05-15 | Carle Vanessa Secretary | Grant or award · Stock Options | +15,000 | 75,000 | ||
| 2025-05-15 | DOCHERTY JOHN MARTIN President | Grant or award · Stock Options | +150,000 | 310,834 | ||
| 2025-05-15 | Shankman Michael Elliot Chief Financial Officer | Grant or award · Stock Options | +50,000 | 100,000 | ||
| 2025-05-15 | Bhullar Baljinder Director | Grant or award · Stock Options | +11,000 | 11,000 | ||
| 2025-05-15 | Baxter Nicholas W Director | Grant or award · Stock Options | +11,000 | 63,000 | ||
| 2025-05-15 | REESE ALBERT L JR Director | Grant or award · Stock Options | +11,000 | 43,000 | ||
| 2025-05-15 | McKechnie William Edward Director | Grant or award · Stock Options | +11,000 | 63,000 | ||
| 2025-01-07 | BUNKA CHRISTOPHER Director | Grant or award | +100,000 | 373,543 | ||
| 2024-12-03 | CHRISTOPHER RICHARD Chief Executive Officer | Purchase | +27,172 | $2.47 | $67K | 50,000 |
| 2024-12-02 | CHRISTOPHER RICHARD Chief Executive Officer | Purchase | +22,828 | $2.24 | $51K | 22,828 |
| 2024-08-12 | TURKEL CATHERINE C. Director | Purchase | +1,600 | $3.13 | $5K | 3,100 |
Page 1 of 6 · 118 trades